Evidence map›Paper›PMID 42145252›Full record

ArticleMovement disorders clinical practice2026

PREDICT-PD: A Two-Stage Approach to Early Identification of Parkinson's Disease.

Sasivimol Virameteekul, Sheena Waters, Brook Huxford, Ashvin Kuri, Manuela Tan, Laura Pérez-Carbonell, Eduardo de Pablo-Fernández, Anette Schrag, Alastair J Noyce, Cristina Simonet

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sasivimol VirameteekulCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID https://orcid.org/0000-0003-0452-164X
Sheena WatersCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID https://orcid.org/0000-0001-7241-2272
Brook HuxfordCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID https://orcid.org/0000-0002-5908-6983
Ashvin KuriCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Manuela TanDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Laura Pérez-CarbonellCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Eduardo de Pablo-FernándezCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
Anette SchragDepartment of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.ORCID https://orcid.org/0000-0002-9872-6680
Alastair J Noyce *Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID https://orcid.org/0000-0003-3027-5497
Cristina Simonet *Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.ORCID https://orcid.org/0000-0002-5555-0283

Funding

Parkinson's UK and Barts Charity G-001226
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersearly detectionParkinson's diseaseprodromal Parkinson's diseaserisk stratification

Identifiers

PMID42145252
PMCPMC13338971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.